Authors



Sunanda Kane, MD

Latest:

Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease

This study evaluated the rates of dose escalation in patients with Crohn's disease.


Jordan E. Anderson, BA

Latest:

Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US Payers

An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.


Jon Kwiatkowski, RPh

Latest:

Copay Organizations and Specialty Pharmacies: Partnering to Help Patients in Need

Copay organizations play an important role in helping patients obtain their medications and have become integral partner with specialty pharmacies as they work together to support different therapies.


Emma Jo Olig, PharmD

Latest:

Antibiotics That Aggravate Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune-mediated neuromuscular disease characterized by muscle weakness.


Pamela Koener, PharmD

Latest:

Rare Pharmacy Emerges From Specialty, Part 3

The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.


N. Lee Rucker, MSPH

Latest:

Applying Value-Based Incentive Models Within Community Pharmacy Practice

Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.




Peter J. Neumann, ScD

Latest:

Findings Related to Assessing Value for Private US Health Plans

A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.


Richard E. Custin, MEd, JD, LLM

Latest:

Chicago Acts to Address Pharmacist Workload and Patient Safety

The City Council Committee on Finance approved a measure that restricts pharmacists to filling orders for no more than 10 patients per hour.


Adam O’Neil, PharmD Candidate

Latest:

Payment for Pharmacists’ Care: Pulling the Linchpin

The emergence of a new Medicare Advantage plan, Troy Medicare, offers much needed momentum to drive pharmacists’ services.


Caroline Tee, PharmD, BCPS

Latest:

MRSA: Challenges and Updates

Selection of optimal antibiotic therapy is crucial in the treatment of MRSA.


Joseph L. Fink, BPharm, JD, DSc (Hon), FAPhA

Latest:

Pharmacist Challenges Revocation of License to Practice

Guilty plea relates to shortcomings in recordkeeping of controlled substances 10 years earlier.



Drew Hardman

Latest:

Home Infusion of Thyroid Eye Disease Treatment Shows Efficacy of Home Care During Pandemic

Home infusion of teprotumumab-trbw (Tepezza), a breakthrough treatment for thyroid eye disease, was found to effectively minimize the chance of infection with coronavirus disease 2019 for both patients and staff of Chartwell Pennsylvania, LP.




Samantha Troy

Latest:

Cytomegalovirus Disease Prevention in High-Risk Liver Transplant Patients: Preemptive Therapy or Prophylaxis?

Organ transplants from seropositive donors carry a high risk of infection from the transplanted organ.


Meghan Ross, Associate Editor

Latest:

Social Media for Pharmacists: How to Be Professional and Engaging

Social media can help pharmacists take control over their brand image.


Alan W.Y. Chock, PharmD

Latest:

Controlling Diabetes: Teaching Patients to Take Charge

The American Diabetes Association recommends that health care providers incorporate an estimated average glucose measurement when counseling patients with diabetes.


Safiya Abouzaid, PharmD

Latest:

Impact of Patient Cost Sharing on Multiple Sclerosis Treatment

This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.


Mumtaz Ibrahim, MD

Latest:

Drivers of Change in Pharmacy Benefit Management

Executive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.


an

Latest:

Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric Hospital

Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.


Royce Burrus, MBA, RPh, FASCP

Latest:

What Does Excellence in Oncology Pharmacy Look Like?

Study results have demonstrated that pharmacists are effective partners in improving care, reducing cost, and avoiding drug complications for patients with cancer.


David M. Suchanek, RPh

Latest:

Specialty in Retail: What Does It Take to Participate?

A retailer's decision to get involved in the specialty pharmacy marketplace should be an informed one that encompasses careful research and a full understanding of all of the stakeholder requirements.


Jared Kaltwasser

Latest:

Edge Detection Might Help Explain Range in Quality of Life for Patients With Advanced Cases

Patients with this severe condition seem to experience significant differences in quality of life despite having similar visual fields


Lindsay R. Kohler, PharmD Candidate

Latest:

Drug Shortages Have Monstrous Effects on Health Care

The Food and Drug Administration Safety and Innovation Act was signed into law in 2012, but the crisis continues.


Natan R. Kahan, PhD, RPh, MHA

Latest:

Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification System

A controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.


Steve Mink

Latest:

Addressing Specialty Drug Access and Affordability Issues

Patients can benefit significantly by having support throughout their treatment journey, starting with access and minimizing financial barriers.